453 related articles for article (PubMed ID: 12199724)
41. Gabapentin in generalized seizures.
Chadwick D; Leiderman DB; Sauermann W; Alexander J; Garofalo E
Epilepsy Res; 1996 Nov; 25(3):191-7. PubMed ID: 8956916
[TBL] [Abstract][Full Text] [Related]
42. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
[TBL] [Abstract][Full Text] [Related]
43. Effect of anticonvulsants on nocturnal sleep in epilepsy.
Placidi F; Diomedi M; Scalise A; Marciani MG; Romigi A; Gigli GL
Neurology; 2000; 54(5 Suppl 1):S25-32. PubMed ID: 10718681
[TBL] [Abstract][Full Text] [Related]
44. [Safety and tolerability of gabapentin].
Viteri C
Rev Neurol; 2002 Feb 1-15; 34(3):292-5. PubMed ID: 12022084
[TBL] [Abstract][Full Text] [Related]
45. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.
Leiderman DB
Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475
[TBL] [Abstract][Full Text] [Related]
46. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.
Reunanen M; Dam M; Yuen AW
Epilepsy Res; 1996 Mar; 23(2):149-55. PubMed ID: 8964276
[TBL] [Abstract][Full Text] [Related]
47. [Gabapentin in 50 patients with epilepsy].
Gracia-Fleta F; Medrano-Martínez V; Castaño-Pérez MD; Hernández-Lorido R; Mañes R
Rev Neurol; 2001 Jan 1-15; 32(1):45-9. PubMed ID: 11293098
[TBL] [Abstract][Full Text] [Related]
48. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study.
Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E
Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405
[TBL] [Abstract][Full Text] [Related]
49. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
Schapel G; Chadwick D
Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
[TBL] [Abstract][Full Text] [Related]
50. A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy.
Crawford P; Brown S; Kerr M;
Seizure; 2001 Mar; 10(2):107-15. PubMed ID: 11407953
[TBL] [Abstract][Full Text] [Related]
51. [Lamotrigine in refractory partial and general epilepsies].
Mauri-Llerda JA; Tejero C; Espada F; Iñiguez C; Morales F
Rev Neurol; 2001 Jan 1-15; 32(1):42-5. PubMed ID: 11293097
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG
Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180
[TBL] [Abstract][Full Text] [Related]
53. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group].
Herranz JL; Sol JM; Hernández G
Rev Neurol; 2000 Jun 16-30; 30(12):1141-5. PubMed ID: 10935239
[TBL] [Abstract][Full Text] [Related]
54. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
Lindberger M; Alenius M; Frisén L; Johannessen SI; Larsson S; Malmgren K; Tomson T
Epilepsia; 2000 Oct; 41(10):1289-95. PubMed ID: 11051124
[TBL] [Abstract][Full Text] [Related]
55. Gabapentin and lamotrigine: novel antiepileptic drugs.
Btaiche IF; Woster PS
Am J Health Syst Pharm; 1995 Jan; 52(1):61-9. PubMed ID: 12879525
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.
Johannessen SI
Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
[TBL] [Abstract][Full Text] [Related]
58. Monostars: an aid to choosing an antiepileptic drug as monotherapy.
Brodie MJ
Epilepsia; 1999; 40 Suppl 6():S17-22; discussion S73-4. PubMed ID: 10530678
[TBL] [Abstract][Full Text] [Related]
59. Coadministration of gabapentin or MK-801 with lamotrigine slows tolerance to its anticonvulsant effects on kindled seizures.
Zhang ZJ; Russell S; Obeng K; Postma T; Obrocea G; Weiss SR; Post RM
Pharmacol Biochem Behav; 2003 Feb; 74(3):565-71. PubMed ID: 12543220
[TBL] [Abstract][Full Text] [Related]
60. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.
Messenheimer J; Ramsay RE; Willmore LJ; Leroy RF; Zielinski JJ; Mattson R; Pellock JM; Valakas AM; Womble G; Risner M
Epilepsia; 1994; 35(1):113-21. PubMed ID: 8112232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
